MRD negativity: considerations for older adults with multiple myeloma

• Hira Mian,
• Tanya M. Wildes,
• Christopher P. Venner,
• Rafael Fonseca

Affiliations

Hira Mian

Department of Oncology, McMaster University

Tanya M. Wildes

Department of Hematology/Oncology, University of Nebraska Medical Center/Nebraska Medicine

Christopher P. Venner

Department of Medical Oncology, Centre for Lymphoid Cancers, University of British Columbia

Rafael Fonseca

Division of Hematology and Medical Oncology, Mayo Clinic in Arizona